ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,176,000 | -39.4% | 451,637 | -0.0% | 0.00% | -33.3% |
| Q2 2022 | $3,592,000 | -42.0% | 451,827 | +7.2% | 0.00% | -25.0% |
| Q1 2022 | $6,189,000 | -27.3% | 421,297 | +0.0% | 0.00% | -20.0% |
| Q4 2021 | $8,508,000 | -17.5% | 421,174 | +10.9% | 0.01% | -28.6% |
| Q3 2021 | $10,314,000 | +11.5% | 379,748 | -0.1% | 0.01% | +16.7% |
| Q2 2021 | $9,254,000 | -0.0% | 380,049 | +0.2% | 0.01% | -14.3% |
| Q1 2021 | $9,255,000 | -15.0% | 379,137 | +11.5% | 0.01% | -12.5% |
| Q4 2020 | $10,886,000 | +24.5% | 340,089 | +28.3% | 0.01% | 0.0% |
| Q3 2020 | $8,747,000 | – | 265,138 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
| Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
| Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
| AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
| Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
| GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
| Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
| XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
| Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
| Nantahala Capital Management | 243,290 | $934,234 | 0.06% |